Eukroma Cream 20 Gm (Hydroquinone)

Product Overview

Eukroma Cream 20 g is a topical dermatological preparation manufactured by Yash Pharma Laboratories Pvt Ltd. The product is formulated with hydroquinone as the active ingredient and is specifically indicated for the treatment of hyperpigmentation and melasma. Each tube contains 20 g of cream packaged for single‑use or multi‑use regimens. The cream is designed for external application only and should be kept out of reach of children. For detailed prescribing information, refer to the product label or consult a qualified healthcare professional.

What is Eukroma Cream

Eukroma Cream belongs to the class of tyrosinase inhibitors used in dermatology to lighten localized skin discoloration. The principal active component, hydroquinone, reduces the visibility of dark spots by interfering with melanin synthesis. This medication is marketed under the brand name Eukroma and is available in a 20 g tube format. It is classified within the therapeutic area of cosmetic dermatology, providing a targeted approach to pigmentary disorders.

Uses and Benefits

The primary uses of Eukroma Cream include the reduction of melasma, post‑inflammatory hyperpigmentation, and other forms of localized darkening of the skin. Patients often experience a more even skin tone after consistent application. The cream can be incorporated into a broader skin‑care regimen that may involve sunscreen and moisturizers. Clinical studies have demonstrated its efficacy when used as directed, offering a non‑invasive alternative to procedural treatments.

Key benefits include:

• Targeted reduction of excess melanin
• Improvement of skin appearance in melasma
• Compatibility with daily skin‑care routines
• Available in multiple pack sizes for flexible dosing

How It Works

The mechanism of action of hydroquinone involves competitive inhibition of the enzyme tyrosinase, a pivotal catalyst in the melanin production pathway. By limiting melanin formation, the cream gradually lightens hyperpigmented areas. The effect is dose‑dependent and typically becomes noticeable after several weeks of continuous use. For a deeper scientific overview, see the NIH resource on pigmentary disorders.

Dosage Guidelines

Application should be performed on clean, dry skin of the affected area. A thin layer of Eukroma Cream is sufficient; excessive application does not enhance results and may increase the risk of irritation. The recommended frequency is once daily, preferably in the evening, to minimize exposure to sunlight immediately after application. Treatment duration varies based on individual response, but most clinicians suggest a minimum of eight to twelve weeks before evaluating efficacy.

Pack size options:

• 1 Cream – suitable for initial trial
• 3 Creams – standard therapeutic course
• 6 Creams – extended maintenance phase

Patients are advised to follow the instructions on the label and to consult a dermatologist for personalized guidance.

Side Effects

Most users experience mild, transient skin reactions such as redness, itching, or a burning sensation at the site of application. These effects typically resolve without medical intervention. However, rare but serious adverse events can occur, including contact dermatitis and exogenous ochronosis, a permanent darkening of the skin. If any of these symptoms develop, discontinue use and seek professional advice.

Warnings and Precautions

Eukroma Cream is for external use only and should not be ingested. It is contraindicated in individuals with known hypersensitivity to hydroquinone or any of the formulation excipients. Pregnant or breastfeeding women should avoid its use unless a physician explicitly approves. Sunlight can exacerbate hyperpigmentation; therefore, sunscreen with a minimum SPF of 30 should be applied during daylight hours. Store the product at room temperature, away from moisture and heat. For additional safety information, refer to the FDA drug label database.

Frequently Asked Questions

Q: How long does it take to see results with Eukroma Cream?
A: Visible improvement is usually reported after 4 to 8 weeks of consistent daily application, though individual response may vary.

Q: Can Eukroma Cream be used on facial skin?
A: Yes, it is formulated for facial and body areas affected by hyperpigmentation, but avoid the eyes and mucous membranes.

Q: Is sunscreen necessary while using the cream?
A: Absolutely; UV exposure can reverse the lightening effect and increase the risk of irritation, so broad‑spectrum sunscreen is recommended.

Q: Are there any drug interactions to be aware of?
A: Topical hydroquinone has minimal systemic absorption, but it should not be combined with other strong topical agents without medical supervision.

Q: What should I do if I miss a dose?
A: Apply the missed application as soon as remembered; if it is near the time of the next dose, skip the missed one and resume the regular schedule.

Related Products

• Eukroma Cream (Hydroquinone)
• Hyde Cream (Hydroquinone)
• Hyde Solution 50 ml (Hydroquinone)
• Eukroma KJ Cream 20gm (Hydroquinone/Kojic Acid)
• Eukroma Plus Cream 20gm (Hydroquinone /Tretinoin /Mometasone)
• Melalite Forte Cream (Hydroquinone)
• Melanorm Cream (Hydroquinone)
• Hydroquinone Cream 20 Gm (Generic)
• Hydroquinone 4% Cream (Generic)